Cabaletta Bio, Inc. (CABA) vs CapsoVision, Inc. (CV)
A side-by-side comparison of Cabaletta Bio, Inc. and CapsoVision, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CABA
Cabaletta Bio, Inc.
$1.98HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
CV
CapsoVision, Inc.
$6.35HealthcareDelayed quote: Oct 6, 2026, 10:33 AM EDT
Total return — CABA vs CV
growth of $100 · dividends reinvested · last 1yCABA +33.3% (+33.3%/yr)CV +88.3% (+88.3%/yr)CV compounded faster over this window
CABA CV
CABA vs CV: by the numbers
- •CABA is the larger company ($322M vs $317M market cap).
- •Both run net losses; CABA's is the smaller (0.00% vs -214.74% net margin).
Metrics side by side
Valuation
| Metric | CABA | CV |
|---|---|---|
| P/S ratio | N/A | 22.84 |
| P/B ratio | 1.53 | 24.10 |
Profitability
| Metric | CABA | CV |
|---|---|---|
| Gross margin | 0.00% | 50.88% |
| Operating margin | 0.00% | -188.25% |
| Net margin | 0.00% | -214.74% |
| ROE | -86.10% | -226.56% |
| ROIC | -85.56% | -164.32% |
Growth (annualized)
| Metric | CABA | CV |
|---|---|---|
| Total return CAGR (5Y) | -28.71% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.